[Intermittent treatment of primary chronic polyarthritis].
D000109:Acetylcholine / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000989:Antistreptolysin; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001797:Blood Protein Electrophoresis; D001799:Blood Sedimentation; D005632:Fructose / Q000627:therapeutic use*; D006386:Hemagglutination Tests; D006801:Humans; D007958:Leukocyte Count; D010653:Phenylbutazone / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use*
D011725:Pyridines; D005632:Fructose; D000324:Adrenocorticotropic Hormone; D000989:Antistreptolysin; D010653:Phenylbutazone; D011729:Pyridostigmine Bromide; D000109:Acetylcholine; D001205:Ascorbic Acid
Intermittierende Behandlung der primär chronischen Polyarthritis.